Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Vilaseca A, Bilodeau PA, Gakis G, Savransky A, Mahler Ferreira Oliveira J, Nguyen L, Hooshmand SI, Satyanarayan S, Moseley CE, Haley L, Roy-Hewitson C, Marrodan M, Casallas A, Manin A, Chen H, Hoshina Y, Grzezulkowska A, Carnero Contentti E, Galleguillos L, Upchurch M, Jackson-Tarlton CS, Chu-Yueh Guo J, Fabian M, Virupakshaiah A, Arrambide G, Caparó-Zamalloa C, Paterno R, Waubant E, Ordoñez Boschetti L, Correale J, Villa AM, Banwell B, Marignier R, Pittock SJ, Greenberg B, Bennett JL, Cho T, Clardy S, Solomon AJ, Kister I, Zamvil SS, Gelfand JM, Repovic P, Obeidat AZ, Blackburn K, Tenembaum S, Chen JJ, Sotirchos ES, Levy M, Flanagan EP, and The Americas MOGAD Treatment Group, Murillo F, Syc-Mazurzek SB, Cacciaguerra L, Jiang M, da Silva Rezende NB, Wingerchuk DM, Horsman SE

Open source

DOI: 10.1001/jamaneurol.2026.2220
Published: 2026 Sep 1
Container: JAMA neurology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamaneurol.2026.2220,
  title = {Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.},
  author = {Vilaseca A and Bilodeau PA and Gakis G and Savransky A and Mahler Ferreira Oliveira J and Nguyen L and Hooshmand SI and Satyanarayan S and Moseley CE and Haley L and Roy-Hewitson C and Marrodan M and Casallas A and Manin A and Chen H and Hoshina Y and Grzezulkowska A and Carnero Contentti E and Galleguillos L and Upchurch M and Jackson-Tarlton CS and Chu-Yueh Guo J and Fabian M and Virupakshaiah A and Arrambide G and Caparó-Zamalloa C and Paterno R and Waubant E and Ordoñez Boschetti L and Correale J and Villa AM and Banwell B and Marignier R and Pittock SJ and Greenberg B and Bennett JL and Cho T and Clardy S and Solomon AJ and Kister I and Zamvil SS and Gelfand JM and Repovic P and Obeidat AZ and Blackburn K and Tenembaum S and Chen JJ and Sotirchos ES and Levy M and Flanagan EP and and The Americas MOGAD Treatment Group and Murillo F and Syc-Mazurzek SB and Cacciaguerra L and Jiang M and da Silva Rezende NB and Wingerchuk DM and Horsman SE},
  year = {2026},
  journal = {JAMA neurology},
  doi = {10.1001/jamaneurol.2026.2220},
  url = {https://doi.org/10.1001/jamaneurol.2026.2220}
}

RIS

TY  - JOUR
TI  - Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
AU  - Vilaseca A
AU  - Bilodeau PA
AU  - Gakis G
AU  - Savransky A
AU  - Mahler Ferreira Oliveira J
AU  - Nguyen L
AU  - Hooshmand SI
AU  - Satyanarayan S
AU  - Moseley CE
AU  - Haley L
AU  - Roy-Hewitson C
AU  - Marrodan M
AU  - Casallas A
AU  - Manin A
AU  - Chen H
AU  - Hoshina Y
AU  - Grzezulkowska A
AU  - Carnero Contentti E
AU  - Galleguillos L
AU  - Upchurch M
AU  - Jackson-Tarlton CS
AU  - Chu-Yueh Guo J
AU  - Fabian M
AU  - Virupakshaiah A
AU  - Arrambide G
AU  - Caparó-Zamalloa C
AU  - Paterno R
AU  - Waubant E
AU  - Ordoñez Boschetti L
AU  - Correale J
AU  - Villa AM
AU  - Banwell B
AU  - Marignier R
AU  - Pittock SJ
AU  - Greenberg B
AU  - Bennett JL
AU  - Cho T
AU  - Clardy S
AU  - Solomon AJ
AU  - Kister I
AU  - Zamvil SS
AU  - Gelfand JM
AU  - Repovic P
AU  - Obeidat AZ
AU  - Blackburn K
AU  - Tenembaum S
AU  - Chen JJ
AU  - Sotirchos ES
AU  - Levy M
AU  - Flanagan EP
AU  - and The Americas MOGAD Treatment Group
AU  - Murillo F
AU  - Syc-Mazurzek SB
AU  - Cacciaguerra L
AU  - Jiang M
AU  - da Silva Rezende NB
AU  - Wingerchuk DM
AU  - Horsman SE
PY  - 2026
JO  - JAMA neurology
DO  - 10.1001/jamaneurol.2026.2220
UR  - https://doi.org/10.1001/jamaneurol.2026.2220
ER  -

APA

A, V., PA, B., G, G., A, S., J, M. F. O., L, N., SI, H., S, S., CE, M., L, H., C, R., M, M., A, C., A, M., H, C., Y, H., A, G., E, C. C., L, G., M, U., CS, J., J, C. G., M, F., A, V., G, A., C, C., R, P., E, W., L, O. B., J, C., AM, V., B, B., R, M., SJ, P., B, G., JL, B., T, C., S, C., AJ, S., I, K., SS, Z., JM, G., P, R., AZ, O., K, B., S, T., JJ, C., ES, S., M, L., EP, F., Group, A. T. A. M. T., F, M., SB, S., L, C., M, J., NB, D. S. R., DM, W., & SE, H. (2026). Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.. JAMA neurology. https://doi.org/10.1001/jamaneurol.2026.2220

Source records

pubmed · retrieved 2026-09-26T17:59:22.566Z